A practical reference on RP-HPLC: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-20 and is reviewed periodically as new material appears.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
=== Mother cows: Land quality === Formerly used in real estate transactions in the American Southwest, it was the number of pregnant cows an acre of a given plot of land could support. It acted as a proxy for the agricultural quality, natural resource availability, and arability of a parcel of land.
==== Anorexia as adaptation ==== Studies have hypothesized that disordered eating patterns may also arise secondary to starvation. The results of the Minnesota Starvation Experiment, for example, showed that normal controls will exhibit many of the same behavioral patterns associated with AN when subjected to starvation. Similarly, scientific experiments conducted using mice have suggested that other mammals exhibit these same behaviors, especially compulsive movement, when caloric restriction is induced, likely mediated by various changes in the neuroendocrine system. This has given further rise to the hypothesis that anorexia nervosa and other restrictive eating disorders may be an evolutionarily advantageous adaptive response to a perceived famine in the environment. Recent research has further expanded this perspective, showing how caloric restriction may be adaptive in volatile or uncertain environment - thus potentially explaining the association between an increased risk to develop anorexia nervosa and adverse childhood experiences.
=== Grasslands === It was reported that approximately 34 percent (33.85 million mu; 22,600 km2) of the region's total surface consisted of grassland. This figure is down from approximately 40 percent in the 1990s. The grasslands are spread over the dry desert-steppe area in the northeast (which forms a part of the Inner Mongolian steppe region), and the hilly pastures located on the semi-arid Loess Plateau in the south. It is ascertained that the grasslands of Ningxia have been degraded to various degrees. Scientists debate the extent to which this degradation occurs over space and time. Historical research has also found limited evidence of expanding grassland degradation and desertification in Ningxia. A major component of land management in Ningxia is a ban on open grazing, which has been in place since 2003. The ecological and socio-economic effects of this Grazing Ban in relation to the grasslands and pastoralists' livelihood are contested. The ban stipulates that animal husbandry be limited to enclosed pens and no open grazing be permitted in certain time periods set by the Autonomous Region's People's Government.
Phrixotoxin-1 (PaTx1) – which is composed of 29 amino acids Phrixotoxin-2 (PaTx2) – which is composed of 31 amino acids Phrixotoxin-3 (PaurTx3 or Beta-theraphotoxin-Ps1a) – which is composed of 34 amino acids
The empire had no choice but war to save its prestige, even though Franz Joseph was hesitant and now with Archduke Franz Ferdinand no longer vetoing the Austrian general staff's demands against war, Hotzendorf, always the advocate for war against Serbia to destroy black hand as the organisation was based in Serbia, got his way. A week after delivery of the Austro-Hungarian ultimatum to Serbia; on 28 July, war was declared. Within weeks, the Germans, Russians, French and British had all entered the fray which eventually became known as World War I. On 6 August, Franz Joseph signed the declaration of war against Russia.
Sources: en.wikipedia.org
==== MeSH D12.776.835.725.934 – prokaryotic initiation factors ==== MeSH D12.776.835.725.934.374 – prokaryotic initiation factor-1 MeSH D12.776.835.725.934.562 – prokaryotic initiation factor-2 MeSH D12.776.835.725.934.750 – prokaryotic initiation factor-3
=== Pharmacokinetics === The absorption of flutamide is complete upon oral ingestion. Food has no effect on the bioavailability of flutamide. Steady-state levels of hydroxyflutamide, the active form of flutamide, are achieved after 2 to 4 days administration. Levels of hydroxyflutamide are approximately 50-fold higher than those of flutamide at steady-state. The plasma protein binding of flutamide and hydroxyflutamide are high; 94 to 96% and 92 to 94%, respectively. Flutamide and its metabolite hydroxyflutamide are known to be transported by the multidrug resistance-associated protein 1 (MRP1; ABCC1). Flutamide is metabolized by CYP1A2 (via α-hydroxylation) in the liver during first-pass metabolism to its main metabolite hydroxyflutamide (which accounts for 23% of an oral dose of flutamide one hour post-ingestion), and to at least five other, minor metabolites. Flutamide has at least 10 inactive metabolites total, including 4-nitro-3-fluoro-methylaniline. Flutamide is excreted in various forms in the urine, the primary form being 2-amino-5-nitro-4-(trifluoromethyl)phenol. Flutamide and hydroxyflutamide have elimination half-lives of 4.7 hours and 6 hours in adults, respectively. However, the half-life of hydroxyflutamide is extended to 8 hours after a single dose and to 9.6 hours at steady state) in elderly individuals. The elimination half-lives of flutamide and hydroxyflutamide are regarded as too short to allow for once-daily dosing, and for this reason, flutamide is instead administered three times daily at 8-hour intervals.
The enzyme is a cytochrome P450 protein containing heme, isolated from maize and other grasses. It requires a partner cytochrome P450 reductase for functional expression. This uses nicotinamide adenine dinucleotide phosphate. It is involved in the biosynthesis of protective and allelopathic compounds such as DIMBOA in some plants.
== Use as a protein and peptide vector == MBP is used to increase the solubility of recombinant proteins expressed in E. coli. In these systems, the protein of interest is often expressed as a MBP-fusion protein, preventing aggregation of the protein of interest. The mechanism by which MBP increases solubility is not well understood. In addition, MBP can itself be used as an affinity tag for purification of recombinant proteins. The fusion protein binds to amylose columns while all other proteins flow through. The MBP-protein fusion can be purified by eluting the column with maltose. Once the fusion protein is obtained in purified form, the protein of interest is often cleaved from MBP with a specific protease and can then be separated from MBP by affinity chromatography. A first study of the relations between structure and functions of MBP was performed by random insertion of a short DNA fragment, coding for a BamHI restriction site, into the malE gene. Some of the insertions affected the functions of MBP whereas others were permissive. The permissive sites that were internal to MBP, were used to insert antigenic peptides and challenge the immune response in mice. The 3'-OH terminal insertions were used to create fusion proteins and develop the use of MBP as an affinity handle for the purification of foreign proteins and peptides by affinity chromatography on cross-linked amylose and elution with maltose in mild physico-chemical conditions. Several plasmid vectors were developed to facilitate the expression and purification of such fusion proteins.
Sources: en.wikipedia.org
At the 1995 EuroBasket in Athens, its first international competition, the FR Yugoslav team, which was led by head coach Dušan Ivković, featured a starting five full of world-class talent, with established European stars at positions one through four — 27-year-old Saša Đorđević, 25-year-old Predrag Danilović, 29-year-old Žarko Paspalj, 22-year-old Dejan Bodiroga — capped off with 27-year-old Vlade Divac, the starting center for the LA Lakers at the five position. With a bench that was just as capable — with experienced Zoran Sretenović (the only player over 30 in the team), Saša Obradović, talisman power forward Zoran Savić, and up-and-coming young center Željko Rebrača — the team rampaged through its preliminary group, which featured medal contenders Greece and Lithuania, with a 6–0 record. At the first direct elimination stage, the quarterfinals, the FR Yugoslavia scored 104 points to destroy France, thus setting up a semifinal clash with the tournament hosts Greece. In the highly charged atmosphere of the OAKA Indoor Arena, the FR Yugoslav team demonstrated its versatility, using defensive prowess in that game to pull off a famous eight-point win, in a tense, low-scoring 60–52 game. In the final, the FR Yugoslavia played against the experienced Lithuanian team, which was led by basketball legend Arvydas Sabonis, in addition to other world class players like Šarūnas Marčiulionis, Rimas Kurtinaitis, and Valdemaras Chomičius. The final became a classic game of international basketball, with the Yugoslavs prevailing, by a score of 96–90, behind Đorđević's 41 points.
=== In model organisms === The E. coli bacterium and S. cerevisiae yeast are two model organisms commonly used for biological study. They are also used as expression systems for producing selenium-substituted proteins, which are used in a form of X-ray crystallography called single- or multi-wavelength anomalous diffraction to determine the tertiary structure of a protein. For these organisms to produce substituted proteins, they are grown in high-selenium environments, which also results in signs of toxicity. Part of this toxicity is due to the random substitution of methionine and cysteine in proteins with the selenium-containing version. Although this is the precise goal of this kind of protein production, alternation of the organism's own proteins in this way can render them nonfunctional.
Hair loss (alopecia) can be caused by chemotherapy that kills rapidly dividing cells; other medications may cause hair to thin. These are most often temporary effects: hair usually starts to regrow a few weeks after the last treatment, but sometimes with a change in color, texture, thickness or style. Sometimes hair has a tendency to curl after regrowth, resulting in "chemo curls." Severe hair loss occurs most often with drugs such as doxorubicin, daunorubicin, paclitaxel, docetaxel, cyclophosphamide, ifosfamide and etoposide. Valproate, a medication used to treat epilepsy, can also make the hair become curly for comparison. Permanent thinning or hair loss can result from some standard chemotherapy regimens. Chemotherapy induced hair loss occurs by a non-androgenic mechanism, and can manifest as alopecia totalis, telogen effluvium, or less often alopecia areata. It is usually associated with systemic treatment due to the high mitotic rate of hair follicles, and more reversible than androgenic hair loss, although permanent cases can occur. Chemotherapy induces hair loss in women more often than men. Scalp cooling offers a means of preventing both permanent and temporary hair loss; however, concerns about this method have been raised.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.